Literature DB >> 31270457

Isomerization of BRCA1-BARD1 promotes replication fork protection.

Manuel Daza-Martin1,2, Katarzyna Starowicz1, Mohammed Jamshad1, Stephanie Tye3, George E Ronson1, Hannah L MacKay1, Anoop Singh Chauhan1, Alexandra K Walker1, Helen R Stone1, James F J Beesley1, Jennifer L Coles1,4, Alexander J Garvin1, Grant S Stewart1, Thomas J McCorvie3, Xiaodong Zhang3, Ruth M Densham5, Joanna R Morris6.   

Abstract

The integrity of genomes is constantly threatened by problems encountered by the replication fork. BRCA1, BRCA2 and a subset of Fanconi anaemia proteins protect stalled replication forks from degradation by nucleases, through pathways that involve RAD51. The contribution and regulation of BRCA1 in replication fork protection, and how this role relates to its role in homologous recombination, is unclear. Here we show that BRCA1 in complex with BARD1, and not the canonical BRCA1-PALB2 interaction, is required for fork protection. BRCA1-BARD1 is regulated by a conformational change mediated by the phosphorylation-directed prolyl isomerase PIN1. PIN1 activity enhances BRCA1-BARD1 interaction with RAD51, thereby increasing the presence of RAD51 at stalled replication structures. We identify genetic variants of BRCA1-BARD1 in patients with cancer that exhibit poor protection of nascent strands but retain homologous recombination proficiency, thus defining domains of BRCA1-BARD1 that are required for fork protection and associated with cancer development. Together, these findings reveal a BRCA1-mediated pathway that governs replication fork protection.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31270457     DOI: 10.1038/s41586-019-1363-4

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  52 in total

1.  RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.

Authors:  Huzefa Dungrawala; Kamakoti P Bhat; Rémy Le Meur; Walter J Chazin; Xia Ding; Shyam K Sharan; Sarah R Wessel; Aditya A Sathe; Runxiang Zhao; David Cortez
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

2.  Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.

Authors:  Katharina Schlacher; Nicole Christ; Nicolas Siaud; Akinori Egashira; Hong Wu; Maria Jasin
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

3.  A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.

Authors:  Anderson T Wang; Taeho Kim; John E Wagner; Brooke A Conti; Francis P Lach; Athena L Huang; Henrik Molina; Erica M Sanborn; Heather Zierhut; Belinda K Cornes; Avinash Abhyankar; Carrie Sougnez; Stacey B Gabriel; Arleen D Auerbach; Stephen C Kowalczykowski; Agata Smogorzewska
Journal:  Mol Cell       Date:  2015-08-06       Impact factor: 17.970

Review 4.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

5.  Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection.

Authors:  Karina Zadorozhny; Vincenzo Sannino; Ondrej Beláň; Jarmila Mlčoušková; Mário Špírek; Vincenzo Costanzo; Lumír Krejčí
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

Review 6.  Protection or resection: BOD1L as a novel replication fork protection factor.

Authors:  Martin R Higgs; Grant S Stewart
Journal:  Nucleus       Date:  2016-02-18       Impact factor: 4.197

7.  Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis.

Authors:  Yoshitami Hashimoto; Arnab Ray Chaudhuri; Massimo Lopes; Vincenzo Costanzo
Journal:  Nat Struct Mol Biol       Date:  2010-10-10       Impact factor: 15.369

8.  A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.

Authors:  Najim Ameziane; Patrick May; Anneke Haitjema; Henri J van de Vrugt; Sari E van Rossum-Fikkert; Dejan Ristic; Gareth J Williams; Jesper Balk; Davy Rockx; Hong Li; Martin A Rooimans; Anneke B Oostra; Eunike Velleuer; Ralf Dietrich; Onno B Bleijerveld; A F Maarten Altelaar; Hanne Meijers-Heijboer; Hans Joenje; Gustavo Glusman; Jared Roach; Leroy Hood; David Galas; Claire Wyman; Rudi Balling; Johan den Dunnen; Johan P de Winter; Roland Kanaar; Richard Gelinas; Josephine C Dorsman
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

9.  A game of substrates: replication fork remodeling and its roles in genome stability and chemo-resistance.

Authors:  Julia Sidorova
Journal:  Cell Stress       Date:  2017-12-05

10.  Fork Protection and Therapy Resistance in Hereditary Breast Cancer.

Authors:  Sharon B Cantor; Jennifer A Calvo
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2018-02-22
View more
  37 in total

1.  A Novel Mechanism to Induce BRCAness in Cancer Cells.

Authors:  Changmeng Cai
Journal:  Cancer Res       Date:  2020-07-15       Impact factor: 12.701

Review 2.  Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease.

Authors:  Sarah A Joseph; Angelo Taglialatela; Giuseppe Leuzzi; Jen-Wei Huang; Raquel Cuella-Martin; Alberto Ciccia
Journal:  DNA Repair (Amst)       Date:  2020-08-15

Review 3.  The BRCA1/BARD1 ubiquitin ligase and its substrates.

Authors:  Samuel R Witus; Mikaela D Stewart; Rachel E Klevit
Journal:  Biochem J       Date:  2021-09-30       Impact factor: 3.857

Review 4.  BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis.

Authors:  John J Krais; Neil Johnson
Journal:  Cancer Res       Date:  2020-08-03       Impact factor: 12.701

5.  Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling.

Authors:  Diego Dibitetto; Jennie R Sims; Carolline F R Ascenção; Kevin Feng; Dongsung Kim; Susannah Oberly; Raimundo Freire; Marcus B Smolka
Journal:  NAR Cancer       Date:  2020-05-01

6.  Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition.

Authors:  Man-Li Luo; Fang Zheng; Wenying Chen; Zhi-Mei Liang; Gurushankar Chandramouly; Jianan Tan; Nicholas A Willis; Chun-Hau Chen; Mateus de Oliveira Taveira; Xiao Zhen Zhou; Kun Ping Lu; Ralph Scully; Gerburg M Wulf; Hai Hu
Journal:  Cancer Res       Date:  2020-03-19       Impact factor: 12.701

7.  Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.

Authors:  Kasper Fugger; Ilirjana Bajrami; Mariana Silva Dos Santos; Sarah Jane Young; Simone Kunzelmann; Geoff Kelly; Graeme Hewitt; Harshil Patel; Robert Goldstone; Thomas Carell; Simon J Boulton; James MacRae; Ian A Taylor; Stephen C West
Journal:  Science       Date:  2021-04-09       Impact factor: 47.728

8.  The emerging determinants of replication fork stability.

Authors:  Tanay Thakar; George-Lucian Moldovan
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

Review 9.  The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.

Authors:  Madalena Tarsounas; Patrick Sung
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-24       Impact factor: 94.444

10.  BRCA1 Mutational Complementation Induces Synthetic Viability.

Authors:  Joseph Nacson; Daniela Di Marcantonio; Yifan Wang; Andrea J Bernhardy; Emma Clausen; Xiang Hua; Kathy Q Cai; Esteban Martinez; Wanjuan Feng; Elsa Callén; Wei Wu; Gaorav P Gupta; Joseph R Testa; André Nussenzweig; Stephen M Sykes; Neil Johnson
Journal:  Mol Cell       Date:  2020-04-30       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.